Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck
Clinical Research | News | 0 Comment | 03 Dec, 2019
Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...Read more
Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC
Clinical Research | News | 0 Comment | 22 Nov, 2019
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...Read more
Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer
Clinical Research | News | 0 Comment | 22 Nov, 2019
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...Read more
CStone announces first patient dosed in the Phase I study of ivosidenib
Clinical Research | News | 0 Comment | 20 Nov, 2019
CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...Read more
Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD
Clinical Research | News | 0 Comment | 11 Nov, 2019
AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...Read more
World first clinical trial commences in alcohol use disorder
Clinical Research | News | 0 Comment | 28 Oct, 2019
A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...Read more
SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019
Clinical Research | News | 0 Comment | 22 Oct, 2019
The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...Read more
ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis
Clinical Research | News | 0 Comment | 22 Oct, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...Read more
Rentschler Biopharma to expand Japanese operation base
Clinical Research | News | 0 Comment | 23 Oct, 2019
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...Read more
ImaginAb inks pact with three global pharma companies
Clinical Research | News | 0 Comment | 15 Oct, 2019
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...Read more
Thermo Fisher expands clinical trials capabilities in China
Clinical Research | News | 0 Comment | 26 Sep, 2019
Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...Read more
WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study
Clinical Research | News | 0 Comment | 20 Sep, 2019
The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...Read more
Japan's Solasia set to start trials for Darinaparsin
Clinical Research | News | 0 Comment | 20 Sep, 2019
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...Read more
ASLAN presents Ph2 study data for Varlitinib tested on BTC patients
Clinical Research | News | 0 Comment | 19 Sep, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...Read more
Covance unveils new R&D center in Shanghai
Clinical Research | News | 0 Comment | 17 Sep, 2019
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...Read more
Novotech highlights South Korea's plans on clinical trials advancements
Clinical Research | News | 0 Comment | 16 Sep, 2019
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...Read more
Strekin AG completes patient recruitment in RESTORE Ph3 of STR001
Clinical Research | News | 0 Comment | 15 Sep, 2019
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...Read more
IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”
Clinical Research | News | 0 Comment | 02 Sep, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...Read more